Cargando…

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global threat. Carbapenem-resistant Gram-negative pathogens and their main representatives Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa are ranked in the highest priority category for new t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giamarellou, Helen, Karaiskos, Ilias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394369/ https://www.ncbi.nlm.nih.gov/pubmed/35892399 http://dx.doi.org/10.3390/antibiotics11081009

Ejemplares similares

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
por: Karaiskos, Ilias, et al.
Publicado: (2014)

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
por: Falagas, Matthew E, et al.
Publicado: (2005)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Burden of extensively drug-resistant and pandrug-resistant Gram-negative bacteria at a tertiary-care centre
por: Bhatt, Puneet, et al.
Publicado: (2015)

Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)

2475. Incidence of Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Gram-Negative Bacteria in Brazilian Intensive Care Units
por: Souza, Gregory Lauar, et al.
Publicado: (2019)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
por: Karakonstantis, Stamatis, et al.
Publicado: (2021)

Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria
por: Charles, Pierre Emmanuel, et al.
Publicado: (2008)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Risk factors for bronchial acquisition of resistant Gram-negative bacteria in critically ill patients and outcome
por: Papakonstantinou, I, et al.
Publicado: (2012)

Antimicrobial Stewardship in the Hospital Setting: A Narrative Review
por: Giamarellou, Helen, et al.
Publicado: (2023)

Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review
por: Chiusaroli, Lorenzo, et al.
Publicado: (2022)

Mortality of Pandrug-Resistant Klebsiella pneumoniae Bloodstream Infections in Critically Ill Patients: A Retrospective Cohort of 115 Episodes
por: Papadimitriou-Olivgeris, Matthaios, et al.
Publicado: (2021)

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma
por: Ceccarelli, Giancarlo, et al.
Publicado: (2022)

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
por: Choe, Junsu, et al.
Publicado: (2019)

The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19
por: de Macedo, Viviane, et al.
Publicado: (2022)

Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
por: Zowawi, Hosam M., et al.
Publicado: (2015)

Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
por: Breijyeh, Zeinab, et al.
Publicado: (2020)

Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria
por: Gontijo, Marco Túlio Pardini, et al.
Publicado: (2021)

Gram-negative bacteremia is an independent predisposing factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2007)

Large vessel vasculitis in a patient with acute Q-fever: A case report
por: Baziaka, Fotini, et al.
Publicado: (2014)

Prevalence of multidrug resistance, extensive drug resistance and pandrug resistance among multiple Gram-negative isolates: experience in a tertiary-care hospital ICU in North India
por: Dewan, S, et al.
Publicado: (2013)

Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria
por: Overly Cottom, Claire, et al.
Publicado: (2023)

Difficult tracheal intubation in critically ill
por: Ahmed, Armin, et al.
Publicado: (2018)

Eradication of Resistant and Susceptible Aerobic Gram-Negative Bacteria From the Digestive Tract in Critically Ill Patients; an Observational Cohort Study
por: Buitinck, Sophie H., et al.
Publicado: (2022)

Bifurcation kinetics of drug uptake by Gram-negative bacteria
por: Westfall, David A., et al.
Publicado: (2017)

Resistant Gram-Negative Bacteria and Diagnostic Point-of-Care Options for the Field Setting during Military Operations
por: Frickmann, Hagen, et al.
Publicado: (2018)

Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria
por: Watkins, Richard R., et al.
Publicado: (2019)

New treatment options against gram-negative organisms
por: Bassetti, Matteo, et al.
Publicado: (2011)

Gram-negative infections: evolving treatments with expanding options
por: Villegas, Maria Virginia, et al.
Publicado: (2018)

648. Cefiderocol as Rescue Therapy for Pseudomonas aeruginosa and Other Difficult-To-Treat Gram-Negative Infections
por: Chou, Andrew, et al.
Publicado: (2022)

Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
por: Kim, Hyeon soo, et al.
Publicado: (2021)

Top-Down LESA Mass Spectrometry Protein Analysis of Gram-Positive and Gram-Negative Bacteria
por: Kocurek, Klaudia I., et al.
Publicado: (2017)

Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review
por: Corona, Alberto, et al.
Publicado: (2023)

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019
por: Galani, Irene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a2smqecd1sk5p10ipcmn7pb9vb